Fig. 1 · Structure
Documents & Downloads
Pyrazinib
Radiosensitiser
Pyrazinib is a potent radiosensitizer that targets angiogenesis and metabolic pathways in esophageal adenocarcinoma (EAC) cells, effectively reducing their radioresistance. This compound modulates the secretion of key cytokines, including IL-6, IL-4, IL-8, and IL-13, in radioresistant EAC cell lines. Additionally, Pyrazinib demonstrates significant inhibition of blood vessel formation in zebrafish models, making it a valuable tool for research in cancer therapeutics and radiosensitization strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 200417-97-6 |
| Applications | Radiosensitiser |
| Formula | C12H10N2O |
| Molecular Weight | 198.22 |
| SMILES | OC(C=CC=C1)=C1/C=C/C2=NC=CN=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.